TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please no advertisers. This is a free site for all.
Thank you.


Friday, September 15, 2017

Aussie researchers to conduct world's first study on live brain cells of Parkinson's patients

September 15, 2017





CANBERRA, Sept. 15 (Xinhua) -- Australian researchers have received funding to undertake an in-vitro study of live brain cells in Parkinson's disease patients.
Cedric Bardy, leader of the study from the South Australian Health and Medical Research Institute (SAHMRI), said the team was granted funding from Perpetual IMPACT Philanthropy to discover new molecular targets to treat Parkinson's.
Parkinson's disease is a degenerative disorder of the central nervous system which causes uncontrollable shaking and behavioural problems. The SAHMRI said 32 Australians are diagnosed with the disease every day.
One of the major issues in developing cures for the disease is a lack of access to live neurons to study the disease and test new drugs.
Bardy's team has developed a platform on which live human neurons can be developed and will use the platform to compare biological differences between neurons from Parkinson's patients and healthy subjects.
To generate the brain tissue used for the study, the SAHMRI team uses state-of-the-art cell biology technology to reprogram skin cells into stem cells in a petri dish.
"We have wasted too much energy and often created false hope in rushing through clinical trials that have failed. We need to rethink our strategy, and I believe developing better and more realistic human pre-clinical models is the key to increasing our chances of translational success," Bardy said in a statement on Friday.
"This work is critical in laying the foundations for screening new therapeutics that are needed to stop the debilitating progression of Parkinson's. If successful for this Parkinson's project, our approach may be extended to all kinds of brain disorders."

http://news.xinhuanet.com/english/2017-09/15/c_136611744.htm

No comments:

Post a Comment